188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment

Mohamed Altai, Helena Wållberg, Hadis Honarvar, Joanna Strand, Anna Orlova, Zohreh Varasteh, Mattias Sandström, John Löfblom, Erik Larsson, Sven-Erik Strand, Mark Lubberink, Stefan Ståhl, Vladimir Tolmachev

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment”. Tillsammans bildar de ett unikt fingeravtryck.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science